8-K Filing

Company

Viridian Therapeutics, Inc.\DE

Filed

May 8, 2019

Period of Report

May 8, 2019

Accession Number

0001590750-19-000030

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →